<em>Trypanosoma cruzi</em> STIB980: a TcI strain for drug discovery and reverse genetics (Publications)
Since the first published genome sequence of Trypanosoma cruzi in 2005, there have been tremendous technological advances in genomics, reverse genetics, and assay development for this elusive pathogen
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global... (Publications)
BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical frame
COVID-19 screening in low resource settings using artificial intelligence for chest radiographs and point-of-care blood tests (Publications)
Artificial intelligence (AI) systems for detection of COVID-19 using chest X-Ray (CXR) imaging and point-of-care blood tests were applied to data from four low resource African settings. The performan
Cause of death estimation from verbal autopsies: is the open response redundant or synergistic? (Publications)
Civil registration and vital statistics systems capture birth and death events to compile vital statistics and to provide legal rights to citizens. Vital statistics are a key factor in promoting publi
Shifting from an inpatient to outpatient centered model through transforming the TB financing in ex-Soviet countries (Publications)
INTRODUCTION: In former Soviet Union countries, tuberculosis (TB) financing largely relies on a hospital-centered model. The World Health Organization favors transformation to ambulatory treatment sin
Antiprotozoal activity of natural products from Nigerien plants used in folk medicine (Publications)
In the course of the screening of plants from Niger for antiprotozoal activity, the methanol extract of Cassia sieberiana, and the dichloromethane extracts of Ziziphus mauritiana and Sesamun alatum we
Antiprotozoal activity of azabicyclo-nonanes linked to tetrazole or sulfonamide cores (Publications)
N-(Aminoalkyl)azabicyclo[3.2.2]nonanes possess antiplasmodial and antitrypanosomal activity. A series with terminal tetrazole or sulfonamido partial structure was prepared. The structures of all new c